UK markets open in 7 hours 38 minutes

Novozymes A/S (NVZMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
74.03-1.38 (-1.82%)
At close: 12:43PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 520.97B
Enterprise value 326.04B
Trailing P/E 45.47
Forward P/E 139.80
PEG ratio (5-yr expected) 1269.44
Price/sales (ttm)1.50
Price/book (mrq)1.92
Enterprise value/revenue 31.86
Enterprise value/EBITDA 75.45

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 318.26%
S&P500 52-week change 336.19%
52-week high 376.97
52-week low 355.00
50-day moving average 374.31
200-day moving average 367.50

Share statistics

Avg vol (3-month) 3746
Avg vol (10-day) 31.04k
Shares outstanding 5223.57M
Implied shares outstanding 6277.32M
Float 205.76M
% held by insiders 18.31%
% held by institutions 143.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.84
Forward annual dividend yield 41.14%
Trailing annual dividend rate 35.25
Trailing annual dividend yield 36.96%
5-year average dividend yield 41.39
Payout ratio 451.02%
Dividend date 315 Mar 2018
Ex-dividend date 411 Mar 2021
Last split factor 25:1
Last split date 327 Nov 2011

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 20.68%
Operating margin (ttm)26.46%

Management effectiveness

Return on assets (ttm)11.00%
Return on equity (ttm)26.88%

Income statement

Revenue (ttm)14B
Revenue per share (ttm)50.06
Quarterly revenue growth (yoy)-0.30%
Gross profit (ttm)7.85B
EBITDA 4.78B
Net income avi to common (ttm)2.9B
Diluted EPS (ttm)1.63
Quarterly earnings growth (yoy)8.60%

Balance sheet

Total cash (mrq)1.06B
Total cash per share (mrq)3.81
Total debt (mrq)6.44B
Total debt/equity (mrq)59.77
Current ratio (mrq)1.39
Book value per share (mrq)38.62

Cash flow statement

Operating cash flow (ttm)4.29B
Levered free cash flow (ttm)3.18B